⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

January 1, 2022Molecular Systems Design & Engineering

Evaluation of plant-derived semi-synthetic molecules against BRD3-BD2 protein: a computational strategy to combat breast cancer

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

BRD3-BD2 protein belongs to the bromodomain and extra-terminal domain (BET) protein family.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kumar et al. (2022) studied this question.

synapsesocial.com/papers/6a15623479ff98d0de4e8c91 https://doi.org/10.1039/d1me00183c

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammationOriginal Research · 2020 · 446 citations
2PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical p<i>K</i><sub>a</sub>PredictionsOriginal Research · 2011 · 4,718 citations
3Improved Treatment of Ligands and Coupling Effects in Empirical Calculation and Rationalization of p<i>K</i><sub>a</sub> ValuesOriginal Research · 2011 · 2,037 citations
4Structure-based virtual screening of novel, high-affinity BRD4 inhibitorsOriginal Research · 2014 · 37 citations
5Phytochemical and pharmacological properties of essential oils from<i>Cedrus</i>speciesClinical Trial · 2017 · 61 citations